Effects of continuing or stopping alendronate after 5 years of treatment – the Fracture Intervention Trial Long-term Extension (FLEX) – a randomized trial
Sorry, but you do not have permission to view this content.
Care of the Elderly Resources
Search Knowledge Base by Keyword
-
-
- Session 1: Dementia
- Session 2: Falls & Bone Health
- Session 3: Sleep Disorders
- Session 4: Responsive Behaviours
- Session 5: Advance Care Planning
- Session 6: Urinary Incontinence
- Session 7: Nutrition and Weight Loss
- Session 8: Polypharmacy
- Session 9: Frailty
- Session 10: Movement Disorders
- Session 11: Pain
- Session 12: Mood Disorders
- Session 13: Medical Cannabis Use in Older Adults
- Session 14: Driving and Dementia
- Session 15: Delirium
-
- Session 1: Dementia
- Session 2: Frailty
- Session 3: Responsive Behaviours
- Session 4: Advance Care Planning
- Session 5: Movement Disorders
- Session 6: Sleep Disorders
- Session 7: Falls and Bone Health
- Session 8: Nutrition & Weight Loss
- Session 9: Medical Cannabis
- Session 10: Urinary Incontinence
- Session 11: Polypharmacy
- Session 12: Delirium
- Session 13: Mood Disorders
- Session 14: Pain Management
-
- Session 1: Dementia
- Session 2: Frailty
- Session 3: Sleep Disorders
- Session 4: Delirium
- Session 5: Advance Care Planning
- Session 6: Pain Management
- Session 7: Polypharmacy
- Session 8: Falls & Bone Health
- Session 9: Responsive Behaviours
- Session 10: Driving & Dementia
- Session 11: Mood Disorders
- Session 12: Weight Loss & Appetite
- Session 13: Medical Cannabis
- Session 14: Incontinence
- Session 15: Movement Disorders
-
- Dec 2018 - Advanced Care Planning/Goals of Care
- Nov 2018 - Caregiver Stress & Compassion Fatigue
- Oct 2018 - Delirium
- Oct 2018 - Falls in Older Adults
- Nov 2018 - Frailty
- Nov 2018 - Mood Disorders
- Dec 2018 - Pain Management in Older Adult
- Oct 2018 - Polypharmacy
- Sept 2018 - Responsive Behaviours
- Oct 2018 - Sleep Disorders
-
- Session 1: Medical Cannabis
- Session 2: Driving & Dementia
- Session 3: Dementia
- Session 4: Responsive Behaviours
- Session 5: Incontinence
- Session 6: Advance Care Planning and Goals of Care
- Session 7: Polypharmacy
- Session 8: Sleep Disorders
- Session 9: Mood Disorders
- Session 10: Movement Disorders
- Session 11: Frailty
- Session 12: Pain
- Session 13: Delirium
- Session 14: Falls & Bone Health
-
- Session 1: Dementia
- Session 2: Responsive Behaviours
- Session 3: Driving and Dementia
- Session 4: Medical Cannabis
- Session 5: Frailty
- Session 6: ACP and Goals of Care
- Session 7: Mood Disorders
- Session 8: Polypharmacy
- Session 9: Sleep Disorders
- Session 10: Elder Abuse
- Session 11: Movement Disorders
- Session 12: Pain
- Session 13: Sexuality
- Session 14: Falls & Bone Health
- Session 15: Incontinence
-
- Session 1: Dementia
- Session 2: Engaging Families In Care
- Session 3: Pain
- Session 4: Sexuality and Aging
- Session 5: Responsive Behaviours
- Session 6: Workplace Mental Health
- Session 7: Palliative Care
- Session 8: Depression
- Session 9: Diet and Nutrition
- Session 10: Sleep Disorders
- Session 11: Falls and Bone Health
- Session 12: Polypharmacy
- Session 13: Parkinson's Disease
- Session 14: Delirium
-
- Session 1: Dementia Screening, Assessment and Diagnosis
- Session 2: Sleep Disorders in Older Adults
- Session 3: Cannabis Use in Older Adults
- Session 4: Driving and Dementia
- Session 5: Polypharmacy
- Session 6: Advanced Care Plans (ACP) and Goals of Care
- Session 7: Sexuality in Older Adults
- Session 8: Responsive Behaviors in Dementia
- Session 9: Frailty
- Session 10: Movement Disorders
- Session 11: Managing Pain in the Older Adult
- Session 12: Caregiver Stress
- Session 13: Depression
- Session 14: Incontinence
- Session 15: Delirium
-
- Session 1: Dementia: Screening, Assessment and Diagnosis
- Session 2: Responsive Behaviours in Dementia
- Session 3: Psychosocial Care
- Session 4: Driving and Dementia
- Session 5: Subtypes of Dementia
- Session 6: Consent & Capacity
- Session 7: Depression & Delirium
- Session 8: Care Partner Perspective of Dementia Journey
- Session 10: Intimacy & Sexual Expressions
- Session 11: Advanced Care Planning
-
- Session 1: Responsive Behaviors in Dementia
- Session 2: Reducing Compassion Fatigue
- Session 3: Models of Care
- Session 4: Delirium
- Session 5: Engaging Families
- Session 6: Acute Changes
- Session 7: Equity, Diversity, & Inclusion
- Session 9: End of Life & Palliative Care
- Session 8: Falls & Bone Health
- Session 10: Sexuality, Intimacy & Dementia
-
-
-
- Advance care planning and palliative medicine in advanced dementia: a literature review
- Advance Care Planning in the Elderly
- Advance care planning: A systematic review of randomised controlled trials conducted with older adults
- Barriers to Advance Care Planning at the End of Life: An Explanatory Systematic Review of Implementation Studies
- Early Palliative Care for Patients with Metastatic Non–Small-Cell Lung Cancer
- Illness trajectories and palliative care
- Patient Care Planning Discussions for Patients at the End of Life: An Evidence-Based Analysis
- Additional Resources
- False memories for end-of-life decisions
- The impact of advance care planning of place of death, a hospice retrospective cohort study
- What do Canadians think of advanced care planning- Findings from an online opinion poll
- Guiding a Goals of Care Discussion
-
- Additional Resources
- Advances in managing chronic disease. Research, performance measurement, and quality improvement are key
- Cannabinoids for treatment of chronic non-cancer pain; a systematic review of randomized trials
- Cervico-thoracic or lumbar sympathectomy for neuropathic pain and complex regional pain syndrome (Review)
- Complex regional pain syndrome: diagnosis and treatment
- Diagnosis and Management of Neuropathic Pain: A Balanced Approach to Treatment
- Management of chronic pain in older adults
- Managing chronic pain in elderly patients requires a CHANGE of approach
- Pharmacological Management of Persistent Pain in Older Persons
- Prevalence and impact of pain among older adults in the United States: Findings from the 2011 National Health and Aging Trends Study
- The Abbey pain scale: a 1-minute numerical indicator for people with end-stage dementia
- The role of patient care teams in chronic disease management
- Validation of proposed diagnostic criteria (the “Budapest Criteria”) for Complex Regional Pain Syndrome
- Development and psychometric evaluation of the Pain Assessment in Advanced Dementia (PAINAD) scale.
- Efficacy of treating pain to reduce behavioural disturbances in residents of nursing homes with dementia: cluster randomised clinical trial
- Pain assessment for people with dementia: a systematic review of systematic reviews of pain assessment tools
- Pain management in patients with dementia
- Guideline for opioid therapy and chronic noncancer pain
- Children's self-reports of pain intensity: scale selection, limitations and interpretation
- Assessment tools for problematic opioid use in palliative care: A scoping review
- The Role of Virtual Reality in Improving Health Outcomes for Community-Dwelling Older Adults: Systematic Review
- The effectiveness, suitability, and sustainability of non-pharmacological methods of managing pain in community-dwelling older adults: a systematic review
- Chronic Pain Management during the Covid-19 Pandemic: A Scoping Review
- Show all articles ( 8 ) Collapse Articles
-
- A multicomponent intervention to prevent delirium in hospitalized older patients.
- Clarifying confusion: the confusion assessment method. A new method for detection of delirium
- Delirium in elderly people.
- Delirium in Hospitalized Older Adults.
- Delirium in Older Persons: Advances in Diagnosis and Treatment
- Detecting delirium among hospitalized older patients.
- Interventions for preventing delirium in older people in institutional long-term care (Review)
- Loud and Clear: Sensory Impairment, Delirium, and Functional Recovery in Critical Illness
- Melatonin decreases delirium in elderly patients: A randomized, placebo-controlled trial
- Prevention of delirium in hospitalized older patients: risk factors and targeted intervention strategies.
- Promoting vision and hearing aids use in an intensive care unit
- PHQ - 9 (The Patient Health Questionnaire)
- Additional Resources
- The delirium experience: what is the effect on patients, relatives and staff and what can be done to modify this?
- 6 Proven Strategies to Prevent Delirium in Older Adults
- COVID-19: ICU delirium management during SARS-CoV-2 pandemic
- Neural mechanisms of delirium: current hypotheses and evolving concepts
- Neurologic Features in Severe SARS-CoV-2 Infection
- Non-pharmacological interventions for preventing delirium in hospitalised non-ICU patients
- Delirium pathophysiology - An updated hypothesis of the etiology of acute brain failure
- Prevalence for delirium in stroke patients: A prospective controlled study
- Echolalia
- Delirium in acute stroke: a systematic review and meta-analysis
- Cognitive Predictors of Delirium on Long-Term Follow-Up after TIA and Stroke: Population-Based Cohort Study
- Show all articles ( 9 ) Collapse Articles
-
- A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): a randomised controlled trial
- Depression and risk for Alzheimer Disease: Systematic Review, Meta-analysis, and Metaregression Analysis
- Diagnosis, Classification and Natural History of Degenerative Dementias
- Efficacy of Treating Pain to Reduce Behavioural Disturbances in Residents of Nursing Homes with Dementia - Cluster Randomized Clinical Trial
- Forecasting the global burden of Alzheimer's disease.
- Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria.
- Hypomanic episode improved spontaneously after isolated acute cerebellar infarct: a case report.
- Improving identification of cognitive impairment in primary care.
- Management of mild to moderate Alzheimer’s disease and dementia.
- Mid-life versus late-life depressive symptoms and risk of dementia: Differential effects for Alzheimer’s disease and vascular dementia
- Mood disorders after stroke and their relation to lesion location. A CT scan study.
- Persistent recurrence of hypomania and prosopoaffective agnosia in a patient with right thalamic infarct
- Plasma homocysteine as a risk factor for dementia and Alzheimer's disease.
- Position Statement of the American Association for Geriatric Psychiatry Regarding Principles of Care for Patients With Dementia Resulting From Alzheimer Disease
- Predictors of the impact of nonpharmacologic interventions for agitation in nursing home residents with advanced dementia
- Progression of subcortical ischemic disease from vascular depression to vascular dementia.
- Progressively lowered stress threshold model - understanding behavioral symptoms of dementia
- Provisional diagnostic criteria for depression of Alzheimer disease.
- Quantifying the unmet needs of caregivers of people with dementia
- Screening for mild cognitive impairment: If not now, when?
- Secondary mania of vascular origin in elderly patients: a report of two clinical cases.
- Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia
- Signs and symptoms preceding the diagnosis of Alzheimer’s disease: a systematic scoping review of literature from 1937 to 2016
- Summary of the evidence on modifiable risk factors for cognitive decline and dementia: A population-based perspective
- The association between mood and anxiety disorders with vascular diseases and risk factors in a nationally-representative sample
- The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease
- When Dementia is in the House
- Which unmet needs contribute to behavior problems in persons with advanced dementia
- ‘Vitamin D and cognition in older adults’: updated international recommendations
- Folate, Vitamin B6 and Vitamin B12 Intake and Mild Cognitive Impairment and Probable Dementia in the Women’s Health Initiative Memory Study
- Vitamin D, Cognition and Alzheimer’s Disease: The Therapeutic Benefit is in the D-Tails
- Vitamin B12 and Cognitive Function: An Evidence-Based Analysis
- Vitamin D deficiency as a risk factor for dementia: a systematic review and metaanalysis
- Canadian Consensus Conference on Diagnosis and Treatment of Dementia (CCCDTD)5: Guidelines for management of vascular cognitive impairment
- CCCDTD5: Reducing the risk of later-life dementia. Evidence informing the Fifth Canadian Consensus Conference on the Diagnosis and Treatment of Dementia (CCCDTD-5)
- Effect of Citalopram on Agitation in Alzheimer's Disease – The CitAD Randomized Controlled Trial
- Dementia incidence continues to increase with age in the oldest old: the 90+ study
- Frontotemporal dementia
- Evaluation of Suspected Dementia
- Recommendations of the 5th Canadian Consensus Conference on the diagnosis and treatment of dementia
- Additional Resources
- Which Risk Factors Causally Influence Dementia? A Systematic Review of Mendelian Randomization Studies
- Environmental risk factors for dementia: a systematic review
- Cognitive Reserve, Alzheimer's Neuropathology, and Risk of Dementia: A Systematic Review and Meta-Analysis
- Combining modifiable risk factors and risk of dementia- a systematic review and meta-analysis
- Show all articles ( 30 ) Collapse Articles
-
- Driving Status and Risk of Entry Into Long-Term Care in Older Adults.
- A Novel Low-Cost Solution for Driving Assessment in Individuals with and without Disabilities
- Additional Resources
- Driving Cessation and Health Outcomes in Older Adults
- Driving evaluation methods for able-bodied persons and individuals with lower extremity disabilities- a review of assessment modalities
- Driving Status and Risk of Entry Into Long-Term Care in Older Adults
- Driving with a neurodegenerative disorder: an overview of the current literature
- Effect of memantine on the progression of driving impairment in mild Alzheimer's disease
- How effective is the Trail Making Test (Parts A and B) in identifying cognitively impaired drivers?
- Longitudinal decline of driving safety in Parkinson disease
- Management of mild to moderate Alzheimer’s disease and dementia
- Parkinson's Disease and Driving - Parkinson's Canada Form
- Practice parameter update- evaluation and management of driving risk in dementia- report of the Quality Standards Subcommittee of the American Academy of Neurology
- Systematic Review of Driving Risk and the Efficacy of Compensatory Strategies in Persons with Dementia
- Update on the Risk of Motor Vehicle Collision or Driving Impairment with Dementia: A Collaborative International Systematic Review and Meta-Analysis
- Cognitive Tests and Determining Fitness to Drive in Dementia: A Systematic Review
- Shifting gears versus sudden stops: qualitative study of consultations about driving in patients with cognitive impairment
- Show all articles ( 2 ) Collapse Articles
-
- A Public Health Approach to Fall Prevention among Older Persons in Canada
- Additional Resources
- Clinical Practice Guidelines for the assessment and prevention of falls in Older People
- Effective Exercise for the Prevention of Falls: A Systematic Review and Meta-Analysis
- Exercise to prevent falls in older adults: an updated meta-analysis and best practice recommendations
- Falls & Related Injuries among Older Canadians: Fall-related Hospitalizations & Prevention Initiatives
- Falls, Injuries due to Falls, and the Risk of Admission to a Nursing Home
- Falls: Epidemiology, Pathophysiology, and Relationship to Fracture
- Hip protectors for preventing hip fractures in older people (Review)
- Interventions for preventing falls in older people in care facilities and hospitals (Review)
- Predictors and prognosis of inability to get up after falls among elderly persons
- Prospective Study of the Impact of Fear of Falling on Activities of Daily Living, SF-36 Scores, and Nursing Home Admission
- Public Health Agency of Canada: Report on Seniors' falls in Canada (2005)
- Public Health Agency of Canada: Seniors' Falls In Canada, 2nd Report
- Recent opioid use and fall-related injury among older patients with trauma
- Summary of the Updated American Geriatrics Society/British Geriatrics Society Clinical Practice Guideline for Prevention of Falls in Older Persons
- The Patient Who Falls: “It’s Always a Trade-off”
- The Timed "Up & Go": A Test of Basic Functional Mobility for Frail Elderly Persons
- Video capture of the circumstances of falls in elderly people residing in long-term care: an observational study
- What are the main risk factors for falls amongst older people and what are the most effective interventions to prevent these falls?
- A Model of BMD Changes After Alendronate Discontinuation to Guide Postalendronate BMD Monitoring
- BMD Changes and Predictors of Increased Bone Loss in Postmenopausal Women After a 5-Year Course of Alendronate
- Effect of Bisphosphonate Use on Risk of Postmenopausal Breast Cancer: Results From the Randomized Clinical Trials of Alendronate and Zoledronic Acid
- Effects of continuing or stopping alendronate after 5 years of treatment - the Fracture Intervention Trial Long-term Extension (FLEX) - a randomized trial
- Efficacy of Continued Alendronate for Fractures in Women With and Without Prevalent Vertebral Fracture: The FLEX Trial
- Flex Trial or Horizon Trial related to biphosphonates trial or holiday
- Fracture Prediction After Discontinuation of 4 to 5 Years of Alendronate Therapy: The FLEX Study
- Managing Osteoporosis Patients after Long-Term Bisphosphonate Treatment: Report of a Task Force of the American Society for Bone and Mineral Research
- Mineralization Density Distribution of Postmenopausal Osteoporotic Bone Is Restored to Normal After Long-Term Alendronate Treatment: qBEI and sSAXS Data From the Fracture Intervention Trial Long-Term Extension (FLEX)
- Randomized Trial of Effect of Alendronate Continuation Versus Discontinuation in Women With Low BMD: Results From the Fracture Intervention Trial Long-Term Extension
- Mortality, Independence in Living, and Re-fracture, One Year Following Hip Fracture in Canadians
- Recommendations for preventing fracture in long-term care
- Strategies to overcome barriers to implementing osteoporosis and fracture prevention guidelines in long-term care: a qualitative analysis of action plans suggested by front line staff in Ontario, Canada
- Successful knowledge translation intervention in long-term care: final results from the vitamin D and osteoporosis study (ViDOS) pilot cluster randomized controlled trial
- Survival and functional outcomes after hip fracture among nursing home residents
- The Cost of Injury in Canada - The clock is ticking...
- Show all articles ( 21 ) Collapse Articles
-
- A global clinical measure of fitness and frailty in elderly people
- A simple frailty questionnaire (FRAIL) predicts outcomes in middle aged African Americans.
- A standard procedure for creating a frailty index.
- Association between frailty and delirium in older adult patients discharged from hospital
- Frailty and the Prediction of Negative Health Outcomes: A Meta-Analysis.
- Frailty in Older Adults: Evidence for a Phenotype
- Prevalence and 10-Year Outcomes of Frailty in Older Adults in Relation to Deficit Accumulation
- Risk factors for functional status decline in community-living elderly people: a systematic literature review.
- The effectiveness of a comprehensive geriatric assessment intervention program for frailty in community-dwelling older people: a randomized, controlled trial.
- The impact of frailty and delirium on mortality in older inpatients
- Comprehensive Geriatric Assessment for community-dwelling, high-risk, frail, older people (Protocol)
- Frailty in elderly people
- Frailty in the critically ill: a novel concept
- Additional Resources
- Whey protein ingestion in elderly results in greater muscle protein accrual than ingestion of its constituent essential amino acid content
- Prevalence of and interventions for sarcopenia in ageing adults: a systematic review. Report of the International Sarcopenia Initiative (EWGSOP and IWGS).
- Clinical Frailty Scale
- Risk factors for death in adult COVID-19 patients: Frailty predicts fatal outcome in older patients
- Geriatric syndromes: clinical, research, and policy implications of a core geriatric concept
- Health outcome prioritization to elicit preferences of older persons with multiple health conditions
- Older age and frailty are the chief predictors of mortality in COVID-19 patients admitted to an acute medical unit in a secondary care setting- a cohort study
- Association between anemia and frailty in 13,175 community-dwelling adults aged 50 years and older in China
- Hemoglobin concentration is associated with self-reported disability and reduced physical performance in a community dwelling population of nonagenarians: the Mugello Study
- Association Between Non-Iron-Deficient Anemia and Insomnia Symptoms in Community-Dwelling Older Adults: The Baltimore Longitudinal Study of Aging
- Show all articles ( 9 ) Collapse Articles
-
- 2012 Update: Guidelines for Adult Urinary Incontinence Collaborative Consensus Document for the Canadian Urological Association
- Additional Resources
- Appropriateness of oral drugs for long-term treatment of lower urinary tract symptoms in older persons: results of a systematic literature review and international consensus validation process (LUTS-FORTA 2014)
- AUA White Paper on Nonneurogenic Chronic Urinary Retention: Consensus Definition, Treatment Algorithm, and Outcome End Points.
- Development of a core set of outcome measures for OAB treatment
- Diagnosis and treatment of overactive bladder (non-neurogenic) in adults: AUA/SUFU guideline.
- Flexible-Dose Fesoterodine in Elderly Adults with Overactive Bladder: Results of the Randomized, Double-Blind, Placebo- Controlled Study of Fesoterodine in an Aging Population Trial
- Persistence and adherence with the new beta-3 receptor agonist, mirabegron, versus antimuscarinics in overactive bladder: Early experience in Canada
- The Association Between Anticholinergic Medication Burden and Health Related Outcomes in the ‘Oldest Old’
- The efficacy and tolerability of the Beta 3-adrenoceptor agonist mirabegron for the treatment of symptoms of overactive bladder in older patients
- The neural control of micturition
- Urinary incontinence in frail elderly persons- Report from the 5th International Consultation on Incontinence
- Use of Bladder Antimuscarinics in Older Adults with Impaired Cognition
- Results after sacral nerve stimulation for chronic constipation.
- American Geriatrics Society 2015 Updated Beers Criteria for Potentially Inappropriate Medication Use in Older Adults
- Anticholinergic Drug Use and Risk to Cognitive Performance in Older Adults with Questionable Cognitive Impairment
- Association of Anticholinergic Burden with Cognitive Impairment and Health Care Utilization Among a Diverse Ambulatory Older Adult Population
- Bladder antimuscarinics and cognitive decline in elderly patients
- Consensus validation of the FORTA (Fit fOR The Aged) List- a clinical tool for increasing the appropriateness of pharmacotherapy in the elderly
- Cumulative use of strong anticholinergics and incident dementia- a prospective cohort study
- How to Use the American Geriatrics Society 2015 Beers Criteria
- Show all articles ( 6 ) Collapse Articles
-
- Additional Resources
- Clinical Evidence for Utilizing Cannabinoids in the Elderly
- Effect of Risperidone for the Treatment of Nightmares in Veterans with PTSD
- Medical Marijuana Use in Older Adults
- Position Paper for the Treatment of Nightmare Disorder in Adults: An American Academy of Sleep Medicine Position Paper
- Simplified guideline for prescribing medical cannabinoids in primary care
- Systematic review of systematic reviews for medical cannabinoids
- Systematic review: Efficacy and safety of medical marijuana in selected neurologic disorders
- The Use of a Synthetic Cannabinoid in the Management of Treatment-Resistant Nightmares in Posttraumatic Stress Disorder (PTSD)
- Trial of Prazosin for Post-Traumatic Stress Disorder in Military Veterans
- The influence of cannabinoids on generic traits of neurodegeneration
- Marijuana Use Among Adults 50 Years or Older in the 21st Century
- Topical Medical Cannabis: A New Treatment for Wound Pain-Three Cases of Pyoderma Gangrenosum
- Topical cannabis-based medicines – A novel paradigm and treatment for non-uremic calciphylaxis leg ulcers: An open label trial
- Characteristics and Patterns of Marijuana Use in Community-Dwelling Older Adults
-
- Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 3. Pharmacological Treatments
- Comorbid anxiety disorders in late-life depression: results of a cohort study.
- Comparison of diagnostic performance of Two-Question Screen and 15 depression screening instruments for older adults: Systematic review and meta-analysis
- Depression among older adults: A 20 year update on give common myths and misconceptions
- Depression and risk for Alzheimer Disease: Systematic Review, Meta-analysis, and Metaregression Analysis
- Depression in the elderly
- Depressive Disorders and Symptoms in Older Primary Care Patients: One Year Outcomes
- Executive dysfunction and treatment response in late-life depression
- Exercise for depression
- Late life depression: a comparison of risk factors and symptoms according to age of onset in community dwelling older adults
- Magnetic Resonance Imaging Predictors of Treatment Response in Late-Life Depression
- Managing depression in older age: psychological interventions
- Mid-life versus late-life depressive symptoms and risk of dementia: Differential effects for Alzheimer’s disease and vascular dementia
- Phenomenology of depression in older compared with younger adults: meta-analysis.
- Progression of subcortical ischemic disease from vascular depression to vascular dementia.
- Provisional diagnostic criteria for depression of Alzheimer disease.
- Risk factors for late-onset generalized anxiety disorder: results from a 12-year prospective cohort (the ESPRIT study).
- The prognosis of depression in older patients in general practice and the community. A systematic review.
- Age differences in the prevalence and co-morbidity of DSM-IV major depressive episodes: Results from the WHO World Mental Health Survey Initiative
- Additional Resources
- Sertraline and Mirtazapine Versus Placebo in Subgroups of Depression in Dementia: Findings From the HTA-SADD Randomized Controlled Trial
- Impact of SSRI Therapy on Risk of Conversion From Mild Cognitive Impairment to Alzheimer’s Dementia in Individuals With Previous Depression
- Music-based therapeutic interventions for people with dementia
- Non-pharmacological Approaches to Depressed Elderly with No or Mild Cognitive Impairment in Long-Term Care Facilities. A Systematic Review of the Literature
- The Effectiveness of Reminiscence Therapy on Alleviating Depressive Symptoms in Older Adults: A Systematic Review
- Show all articles ( 10 ) Collapse Articles
-
- 2015 Update on Parkinson disease
- Additional Resources
- Canadian Guidelines on Parkinson’s Disease
- Double-Blind, Double-Dummy, Randomized Study of Continuous Intrajejunal Infusion of Levodopa-Carbidopa Intestinal Gel in Advanced Parkinson's Disease
- Feeding Choices for People with Advanced Parkinson’s Disease
- Mindfulness-based stress reduction in Parkinson’s disease: a systematic review
- Parkinson’s disease dementia: a neural networks perspective
- Parkinson’s disease: clinical features and diagnosis
- Parkinson’s Disease: From Pathogenesis to Pharmacogenomics
- Physical therapist interventions for Parkinson disease.
- Progressive resistance training in Parkinson’s disease: a systematic review and meta-analysis
- Systematic review on strength training in Parkinson’s disease: an unsolved question
- The hallmarks of Parkinson’s disease
- The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the Non-Motor Symptoms of Parkinson's Disease
- Treadmill training for patients with Parkinson’s disease (Review)
- Treatment of Cognitive, Psychiatric, and Affective Disorders Associated with Parkinson’s Disease
- Collective physician perspectives on non-oral medication approaches for the management of clinically relevant unresolved issues in Parkinson's disease
- Practice guideline update summary- Botulinum neurotoxin for the treatment of blepharospasm, cervical dystonia, adult spasticity, and headache
- Parkinson’s disease in the older patient
- Show all articles ( 4 ) Collapse Articles
-
- Mortality, Independence in Living, and Re-fracture, One Year Following Hip Fracture in Canadians
- Recommendations for preventing fracture in long-term care
- Strategies to overcome barriers to implementing osteoporosis and fracture prevention guidelines in long-term care: a qualitative analysis of action plans suggested by front line staff in Ontario, Canada
- Successful knowledge translation intervention in long-term care: final results from the vitamin D and osteoporosis study (ViDOS) pilot cluster randomized controlled trial
- Survival and functional outcomes after hip fracture among nursing home residents
-
- Additional Resources
- American Geriatrics Society 2015 Updated Beers Criteria for Potentially Inappropriate Medication Use in Older Adults
- American Geriatrics Society Updated Beers Criteria for Potentially Inappropriate Medication Use in Older Adults
- Consensus validation of the FORTA (Fit fOR The Aged) List- a clinical tool for increasing the appropriateness of pharmacotherapy in the elderly
- Deciding when to stop: towards evidence-based deprescribing of drugs in older populations
- Feasibility Study of a Systematic Approach for Discontinuation of Multiple Medications in Older Adults
- How to Use the American Geriatrics Society 2015 Beers Criteria
- Individualizing prevention for older adults
- Interventions that can Reduce Inappropriate Prescribing in the Elderly - A Systematic Review
- Polypharmacy in the elderly: a fait accompli?
- Reducing the Risk of Adverse Drug Events in Older Adults
- The war against polypharmacy: a new cost effective geriatric-palliative approach for improving drug therapy in disabled elderly people
- STOPP (Screening Tool of Older Persons’ potentially inappropriate Prescriptions): application to acutely ill elderly patients and comparison with Beers’ criteria
- A systematic review of the evidence for deprescribing interventions among older people living with frailty
-
- Additional Resources
- Assessment and management of behavioral and psychological symptoms of dementia
- Effect of Citalopram on Agitation in Alzheimer's Disease – The CitAD Randomized Controlled Trial
- Efficacy of nonpharmacologic interventions for agitation in advanced dementia: a randomized, placebo-controlled trial.
- Predictors of the impact of nonpharmacologic interventions for agitation in nursing home residents with advanced dementia.
- Progressively Lowered Stress Threshold Model: Understanding Behavioral Symptoms of Dementia
- Quantifying the unmet needs of caregivers of people with dementia: a critical review of the quality of measures
- Which unmet needs contribute to behavior problems in persons with advanced dementia?
- Escitalopram versus risperidone for the treatment of behavioral and psychotic symptoms associated with Alzheimer's disease: a randomized double-blind pilot study.
- Reduction of the Anticholinergic Burden Makes It Possible to Decrease Behavioral and Psychological Symptoms of Dementia.
- Efficacy of treating pain to reduce behavioural disturbances in residents of nursing homes with dementia: cluster randomised clinical trial
- Acupuncture for Behavioral and Psychological Symptoms of Dementia: A Systematic Review and Meta-Analysis
- Acupuncture for Mild Cognitive Impairment and Dementia: An Overview of Systematic Reviews
- Effectiveness and Safety of Aromatherapy in Managing Behavioral and Psychological Symptoms of Dementia: A Mixed-Methods Systematic Review
- Herbal Medicine for Behavioral and Psychological Symptoms of Dementia: A Systematic Review and Meta-Analysis
-
- Can sleep quality and wellbeing be improved by changing the indoor lighting in the homes of healthy, elderly citizens?
- Narcolepsy - Review Article
- Pharmacotherapies for sleep disturbances in dementia (Review)
- Age-related changes of circadian rhythms and sleep-wake cycles
- Association between difficulty initiating sleep in older adults and the combination of leisure-time physical activity and consumption of milk and milk products: a cross-sectional study.
- Effectiveness of melatonin treatment on circadian rhythm disturbances in dementia
- Effects of Diet on Sleep Quality
- Insights into REM Sleep Behavior Disorder Pathophysiology in Brainstem-Predominant Lewy Body Disease
- Melatonin decreases delirium in elderly patients- a randomized placebo-controlled trial
- Music for insomnia in adults
- Sleep Pathologies in Depression and the Clinical Utility of Polysomnography
- Sleep Problems in the Elderly
- Winter is coming- nightmares and sleep problems during seasonal affective disorder
- Additional Resources
- Treatment of sleep disorders in dementia
- Amyloid-beta dynamics are regulated by orexin and the sleep-wake cycle
- Cognitive Behavioral Therapy for Insomnia in Older Veterans Using Nonclinician Sleep Coaches: Randomized Controlled Trial
- Dismantling multicomponent behavioral treatment for insomnia in older adults: a randomized controlled trial
- Duration and quality of sleep among Canadians aged 18 to 79
- Efficacy of brief behavioral treatment for chronic insomnia in older adults
- Insomnia (primary) in older people
- Insomnia in the Elderly: A Review
- Optimizing sleep in older adults: treating insomnia
- The effect of magnesium supplementation on primary insomnia in elderly: A double-blind placebo-controlled clinical trial
- Sensory Stimulation for Nursing-Home Residents: Systematic Review and Meta-Analysis of Its Effects on Sleep Quality and Rest-Activity Rhythm in Dementia
- Sleep Duration and Sleep Quality in Caregivers of Patients With Dementia: A Systematic Review and Meta-analysis
- Sleep Quality and Aging: A Systematic Review on Healthy Older People, Mild Cognitive Impairment and Alzheimer's Disease
- Show all articles ( 12 ) Collapse Articles
-
- Additional Resources
- Interventions for reducing benzodiazepine use in older people: meta-analysis of randomised controlled trials
- Minimal interventions to decrease long-term use of benzodiazepines in primary care: a systematic review and meta-analysis.
- Screening for alcohol use and misuse in older adults: using the Short Michigan Alcoholism Screening Test--Geriatric Version.
- Treatment of Benzodiazepine Dependence
-
- Additional Resources
- Ageing Is Associated with Decreases in Appetite and Energy Intake—A Meta-Analysis in Healthy Adults
- Short Sleep Duration and Dietary Intake: Epidemiologic Evidence, Mechanisms, and Health Implications
- Unintentional Weight Loss in Older Adults
- An Approach to the Nonpharmacologic and Pharmacologic Management of Unintentional Weight Loss Among Older Adults
- Anorexia of ageing: a key component in the pathogenesis of both sarcopenia and cachexia
- Mechanisms of the anorexia of aging—a review
- Whey protein ingestion in elderly results in greater muscle protein accrual than ingestion of its constituent essential amino acid content
-
-
- Articles coming soon
-
- Abbey Pain Scale for Dementia Patients
- Additional Resources
- Cognigram
- Dementia Observational System (DOS) Tool
- Lawton –Brody Instrumental Activities of Daily Living Scale (IADL)
- MoCA Test
- PAINAD
- Recommendations on screening for cognitive impairment in older adults.
- The GPCOG: a new screening test for dementia designed for general practice.
- The Abbey pain scale: a 1-minute numerical indicator for people with end-stage dementia
- ABC Dementia Scale: A Quick Assessment Tool for Determining Alzheimer’s Disease Severity
-
- Articles coming soon
-
- Articles coming soon
-